Quantcast

Latest Wegener's Granulomatosis Stories

2011-11-07 10:37:10

Study shows psychological health important to controlling Wegener's granulomatosis In patients with a devastating form of vasculitis who are in remission, stress can be associated with a greater likelihood of the disease flaring, according to a new study by investigators at Hospital for Special Surgery (HSS). This is the first study to suggest that mental health is a risk factor in patients with vasculitis, a group of autoimmune disorders characterized by the inflammatory destruction of...

2011-10-28 12:03:12

Substance in the blood blocks repair and contributes to kidney failure     Patients with an autoimmune disease called anti-neutrophil cytoplasmic antibody-associated vasculitis produce antibodies that damage blood vessels in the kidneys.     Patients with the disease harbor elevated blood levels of the protein Flt1, which hinders blood vessel repair.     Inhibiting Flt1 may help prevent kidney failure in the 1:50,000 patients around the world...

2011-04-19 16:10:00

SILVER SPRING, Md., April 19, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Rituxan (rituximab), in combination with glucocorticoids (steroids), to treat patients with Wegener's granulomatosis (WG) and microscopic polyangiitis (MPA), two rare disorders that cause blood vessel inflammation (vasculitis). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) Vasculitis in patients with WG and MPA can lead to tissue damage. WG mostly affects the...

2010-11-09 19:08:37

In a comparison of treatments for maintaining remission of a certain type of vasculitis (inflammation of blood vessels), the immunosuppressant mycophenolate mofetil, regarded as an alternative to the drug often used to prevent relapse, azathioprine, was less effective, according to a study that will appear in the December 1 print edition of JAMA. The study is being released early online to coincide with its presentation at the American College of Rheumatology annual scientific meeting....

2010-07-15 13:55:37

Investigators have made a major advance in treating people with a severe form of vasculitis, anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, a rare but devastating disease of blood vessels. In a six-month study, a new treatment strategy provided the same benefits as the current standard of care used for more than 40 years but required less frequent treatments. Early results also suggest that patients with disease relapses"”typically recurrences of fever, fatigue,...

2010-07-15 13:30:56

Researchers have reported that Rituximab, a drug that is FDA approved to treat B cell lymphoma and rheumatoid arthritis, can also treat severe vasculitis as well as the current standard therapy. Infertility and the development of cancers have been associated with the traditionally used medication, cyclophosphamide, and the risk of these complications is expected to be much lower with Rituximab. The news will be published in the July 14 issue of the New England Journal of Medicine. "The reason...

2010-07-15 13:25:10

 Two UNC School of Medicine faculty authored an editorial in the July 15, 2010 New England Journal of Medicine commenting on results from two clinical trials using the drug Rituximab to treat small-vessel vasculitis, a rare autoimmune disease. The trials took place in the United States "“ Rituximab in ANCA-Associated Vasculitis (RAVE) -- and in Europe -- Rituximab versus cyclophosphamide in ANCA-Associated renal vasculitis (RITUXIVAS). Both trials showed that rituximab was...

2010-06-15 09:28:00

JOHNS CREEK, Ga., June 15 /PRNewswire-FirstCall/ -- Wegener Corporation (Other OTC: WGNR), a leading provider of products for television, audio and data distribution networks worldwide, today announced preliminary operating results for the third quarter ended May 28, 2010. Final results for the third quarter of fiscal 2010 will be released on July 12, 2010. Preliminary operating results for the third quarter of fiscal 2010 were revenues of $2.1 million and a net loss of approximately...

2010-03-09 15:13:00

DULUTH, Ga., March 9 /PRNewswire-FirstCall/ -- Wegener Corporation, (Nasdaq: WGNR) a leading provider of products for television, audio and data distribution networks worldwide, today announced preliminary operating results for the second quarter ended February 26, 2010. Final results for the second quarter of fiscal 2010 will be released on April 12, 2010. Preliminary operating results for the second quarter of fiscal 2010 were revenues of $2.4 million and a net loss of approximately...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related